Power Law company profile

CytomX Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2008 · IPO 2015 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$743M

Market cap · Apr/2026

Revenue

$76M

Latest reported FY

Investors

7 investors on CytomX Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 7 investors entered at this stage

Global footprint

Web traffic by country

27K monthly visits
across markets

🇺🇸 United States76.3%

🇬🇧 United Kingdom6.3%

🇮🇳 India5.6%

🇯🇵 Japan5.2%

🇫🇷 France4.1%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo